The next chapter in immunotherapy and radiation combination therapy: Cancer-specific perspectives Review

  


Authors: Wisdom, A. J.; Barker, C. A.; Chang, J. Y.; Demaria, S.; Formenti, S.; Grassberger, C.; Gregucci, F.; Hoppe, B. S.; Kirsch, D. G.; Marciscano, A. E.; Mayadev, J.; Mouw, K. W.; Palta, M.; Wu, C. C.; Jabbour, S. K.; Schoenfeld, J. D.
Review Title: The next chapter in immunotherapy and radiation combination therapy: Cancer-specific perspectives
Abstract: Immunotherapeutic agents have revolutionized cancer treatment over the past decade. However, most patients fail to respond to immunotherapy alone. A growing body of preclinical studies highlights the potential for synergy between radiation therapy and immunotherapy, but the outcomes of clinical studies have been mixed. This review summarizes the current state of immunotherapy and radiation combination therapy across cancers, highlighting existing challenges and promising areas for future investigation. © 2024 Elsevier Inc.
Keywords: multimodality cancer therapy; combined modality therapy; neoplasm; neoplasms; radiotherapy; clinical study; immunotherapy; combination therapy; diseases; preclinical studies; humans; human; immunotherapeutics; 'current; growing bodies
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 118
Issue: 5
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2024-04-01
Start Page: 1404
End Page: 1421
Language: English
DOI: 10.1016/j.ijrobp.2023.12.046
PUBMED: 38184173
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85187216202&doi=10.1016%2fj.ijrobp.2023.12.046&partnerID=40&md5=33a067f8ec752ad430bbbda4f24cf870
Notes: Review -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Christopher Barker
    218 Barker
Related MSK Work